Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
reCoVery: Chlorpromazine for COVID-19
NCT04366739Phase 3Withdrawn
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Aminazin in coronavirus disease 2019 (COVID-19), sponsored by Centre Hospitalier Sainte-Anne. Planned start Apr 2020; status: withdrawn.
02
Drugs
Aminazin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04366739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366739.